222 related articles for article (PubMed ID: 24876790)
1. Influence of oncogenic transcription factors on chromatin conformation and implications in prostate cancer.
Yang YA; Kim J; Yu J
Appl Clin Genet; 2014; 7():81-91. PubMed ID: 24876790
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic transcription factors as master regulators of chromatin topology: a new role for ERG in prostate cancer.
Elemento O; Rubin MA; Rickman DS
Cell Cycle; 2012 Sep; 11(18):3380-3. PubMed ID: 22918253
[TBL] [Abstract][Full Text] [Related]
3. Oncogene-mediated alterations in chromatin conformation.
Rickman DS; Soong TD; Moss B; Mosquera JM; Dlabal J; Terry S; MacDonald TY; Tripodi J; Bunting K; Najfeld V; Demichelis F; Melnick AM; Elemento O; Rubin MA
Proc Natl Acad Sci U S A; 2012 Jun; 109(23):9083-8. PubMed ID: 22615383
[TBL] [Abstract][Full Text] [Related]
4. Histone modifications and chromatin organization in prostate cancer.
Chen Z; Wang L; Wang Q; Li W
Epigenomics; 2010 Aug; 2(4):551-60. PubMed ID: 21318127
[TBL] [Abstract][Full Text] [Related]
5. TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming.
Iljin K; Wolf M; Edgren H; Gupta S; Kilpinen S; Skotheim RI; Peltola M; Smit F; Verhaegh G; Schalken J; Nees M; Kallioniemi O
Cancer Res; 2006 Nov; 66(21):10242-6. PubMed ID: 17079440
[TBL] [Abstract][Full Text] [Related]
6. The oncogenic gene fusion TMPRSS2: ERG is not a diagnostic or prognostic marker for ovarian cancer.
Huang L; Schauer IG; Zhang J; Mercado-Uribe I; Deavers MT; Huang J; Liu J
Int J Clin Exp Pathol; 2011; 4(7):644-50. PubMed ID: 22076164
[TBL] [Abstract][Full Text] [Related]
7. Genetic interaction between Tmprss2-ERG gene fusion and Nkx3.1-loss does not enhance prostate tumorigenesis in mouse models.
Linn DE; Bronson RT; Li Z
PLoS One; 2015; 10(3):e0120628. PubMed ID: 25780911
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States.
Mosquera JM; Mehra R; Regan MM; Perner S; Genega EM; Bueti G; Shah RB; Gaston S; Tomlins SA; Wei JT; Kearney MC; Johnson LA; Tang JM; Chinnaiyan AM; Rubin MA; Sanda MG
Clin Cancer Res; 2009 Jul; 15(14):4706-11. PubMed ID: 19584163
[TBL] [Abstract][Full Text] [Related]
9. Linking Chromatin Fibers to Gene Folding by Hierarchical Looping.
Bascom G; Schlick T
Biophys J; 2017 Feb; 112(3):434-445. PubMed ID: 28153411
[TBL] [Abstract][Full Text] [Related]
10. Nucleotide resolution analysis of TMPRSS2 and ERG rearrangements in prostate cancer.
Weier C; Haffner MC; Mosbruger T; Esopi DM; Hicks J; Zheng Q; Fedor H; Isaacs WB; De Marzo AM; Nelson WG; Yegnasubramanian S
J Pathol; 2013 Jun; 230(2):174-83. PubMed ID: 23447416
[TBL] [Abstract][Full Text] [Related]
11. Cocaine-Induced Chromatin Modifications Associate With Increased Expression and Three-Dimensional Looping of Auts2.
Engmann O; Labonté B; Mitchell A; Bashtrykov P; Calipari ES; Rosenbluh C; Loh YE; Walker DM; Burek D; Hamilton PJ; Issler O; Neve RL; Turecki G; Hurd Y; Chess A; Shen L; Mansuy I; Jeltsch A; Akbarian S; Nestler EJ
Biol Psychiatry; 2017 Dec; 82(11):794-805. PubMed ID: 28577753
[TBL] [Abstract][Full Text] [Related]
12. TMPRSS2/ERG promotes epithelial to mesenchymal transition through the ZEB1/ZEB2 axis in a prostate cancer model.
Leshem O; Madar S; Kogan-Sakin I; Kamer I; Goldstein I; Brosh R; Cohen Y; Jacob-Hirsch J; Ehrlich M; Ben-Sasson S; Goldfinger N; Loewenthal R; Gazit E; Rotter V; Berger R
PLoS One; 2011; 6(7):e21650. PubMed ID: 21747944
[TBL] [Abstract][Full Text] [Related]
13. 5' UTR control of native ERG and of Tmprss2:ERG variants activity in prostate cancer.
Zammarchi F; Boutsalis G; Cartegni L
PLoS One; 2013; 8(3):e49721. PubMed ID: 23472063
[TBL] [Abstract][Full Text] [Related]
14. TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions.
Cerveira N; Ribeiro FR; Peixoto A; Costa V; Henrique R; Jerónimo C; Teixeira MR
Neoplasia; 2006 Oct; 8(10):826-32. PubMed ID: 17032499
[TBL] [Abstract][Full Text] [Related]
15. Androgen receptor and gene network: Micromechanics reassemble the signaling machinery of TMPRSS2-ERG positive prostate cancer cells.
Farooqi AA; Hou MF; Chen CC; Wang CL; Chang HW
Cancer Cell Int; 2014; 14():34. PubMed ID: 24739220
[TBL] [Abstract][Full Text] [Related]
16. Association of Prostate Cancer Risk Variants with TMPRSS2:ERG Status: Evidence for Distinct Molecular Subtypes.
Penney KL; Pettersson A; Shui IM; Graff RE; Kraft P; Lis RT; Sesso HD; Loda M; Mucci LA
Cancer Epidemiol Biomarkers Prev; 2016 May; 25(5):745-9. PubMed ID: 26941365
[TBL] [Abstract][Full Text] [Related]
17. Detection of TMPRSS2-ERG fusion gene expression in prostate cancer specimens by a novel assay using branched DNA.
Lu B; Maqsodi B; Yang W; McMaster GK; Perner S; Regan M; Bubley GJ; Balk SP; Rubin M; Sanda MG
Urology; 2009 Nov; 74(5):1156-61. PubMed ID: 19647299
[TBL] [Abstract][Full Text] [Related]
18. TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer.
Perner S; Demichelis F; Beroukhim R; Schmidt FH; Mosquera JM; Setlur S; Tchinda J; Tomlins SA; Hofer MD; Pienta KG; Kuefer R; Vessella R; Sun XW; Meyerson M; Lee C; Sellers WR; Chinnaiyan AM; Rubin MA
Cancer Res; 2006 Sep; 66(17):8337-41. PubMed ID: 16951139
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic activation of ERG: A predominant mechanism in prostate cancer.
Sreenath TL; Dobi A; Petrovics G; Srivastava S
J Carcinog; 2011; 10():37. PubMed ID: 22279422
[TBL] [Abstract][Full Text] [Related]
20. TMPRSS2:ERG fusion transcripts in urine from prostate cancer patients correlate with a less favorable prognosis.
Rostad K; Hellwinkel OJ; Haukaas SA; Halvorsen OJ; Øyan AM; Haese A; Budäus L; Albrecht H; Akslen LA; Schlomm T; Kalland KH
APMIS; 2009 Aug; 117(8):575-82. PubMed ID: 19664128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
